ArticleTurkish journal of medical sciences2023

Efficacy of rituximab on disease activity, severity, and disease-related damage in patients with immunosuppressive-resistant systemic sclerosis.

Yasemin Yalçinkaya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.